NCT06543303 - Evaluation of BTV100 in Subjects With Dry Eye Disease | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

February 15, 2026

Study Completion Date

February 15, 2026

Conditions

Dry Eye

Interventions

DRUG

BTV100 Low dose

1% Cevimeline Ophthalmic Solution

DRUG

BTV100 Mid dose

2% Cevimeline Ophthalmic Solution

DRUG

BTV100 High dose

4% Cevimeline Ophthalmic Solution

DRUG

Placebo

Trial Locations (6)

RECRUITING

Cataract and Eye Surgery Centre, Victoria, Doncaster East

RECRUITING

Sydney Eye Hospital, Sydney

RECRUITING

Chang Gung Memorial Hospital-Kaohsiung Branch, Kaohsiung City

RECRUITING

Kaohsiung Veterans General Hospital, Kaohsiung City

RECRUITING

Taipei Veterans General Hospital, Taipei

RECRUITING

Chang Gung Memorial Hospital-LinKou Branch, Taoyuan District